Generate Biomedicines Inc (GENB)

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$11.62
Day's range
$12.32

Generate Biomedicines Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FLAGSHIP PIONEERING INC. 05/15/2026 62.67 M $783.41 M   100.00% 48.89%
FMR LLC 05/15/2026 4.22 M $52.72 M   100.00% 3.29%
CAPITAL WORLD INVESTORS 05/13/2026 4.00 M $50.05 M   100.00% 3.12%
BRAIDWELL LP 05/15/2026 3.59 M $44.91 M   100.00% 2.80%
JPMORGAN CHASE & CO 05/13/2026 2.95 M $33.92 M   100.00% 2.30%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 2.11 M $26.37 M   100.00% 1.65%
ARCH VENTURE MANAGEMENT, LLC 05/15/2026 1.94 M $24.31 M   100.00% 1.52%
HARBOURVEST PARTNERS LLC 05/15/2026 1.72 M $21.53 M   100.00% 1.34%
BAKER BROS. ADVISORS LP 05/15/2026 1.42 M $17.80 M   100.00% 1.11%
HARVARD MANAGEMENT CO INC 05/15/2026 1.11 M $13.89 M   100.00% 0.87%
NVIDIA CORP 05/15/2026 833.33 K $10.42 M   100.00% 0.65%
SIREN, L.L.C. 05/14/2026 736.10 K $9.20 M   100.00% 0.57%
DAVERN CAPITAL PARTNERS, LP 05/14/2026 591.80 K $7.40 M   100.00% 0.46%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2026 500.00 K $6.25 M   100.00% 0.39%
ARK INVESTMENT MANAGEMENT LLC 05/12/2026 498.41 K $6.23 M   100.00% 0.39%
MILLENNIUM MANAGEMENT LLC 05/15/2026 376.89 K $4.71 M   100.00% 0.29%
UBS GROUP AG 05/05/2026 356.70 K $4.46 M   100.00% 0.28%
AFFINITY ASSET ADVISORS, LLC 05/14/2026 350.00 K $4.38 M   100.00% 0.27%
MORGAN STANLEY 05/15/2026 337.30 K $4.22 M   100.00% 0.26%
EXODUSPOINT CAPITAL MANAGEMENT, LP 05/15/2026 311.99 K $3.90 M   100.00% 0.24%
CENTERBOOK PARTNERS LP 05/05/2026 266.81 K $3.34 M   100.00% 0.21%
SPHERA FUNDS MANAGEMENT LTD. 05/15/2026 185.00 K $2.31 M   100.00% 0.14%
GOLDMAN SACHS GROUP INC 05/15/2026 170.70 K $2.13 M   100.00% 0.13%
05/15/2026 131.32 K $1.64 M   100.00% 0.10%
SEVEN GRAND MANAGERS, LLC 05/06/2026 125.00 K $1.56 M   100.00% 0.10%
JANE STREET GROUP, LLC 05/12/2026 123.37 K $1.54 M   100.00% 0.10%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 118.24 K $1.48 M   100.00% 0.09%
LMR PARTNERS LLP 05/15/2026 100.00 K $1.25 M   100.00% 0.08%
SILVERARC CAPITAL MANAGEMENT, LLC 05/14/2026 100.00 K $1.25 M   100.00% 0.08%
D. E. SHAW & CO., INC. 05/15/2026 95.00 K $1.19 M   100.00% 0.07%
AMERIPRISE FINANCIAL INC 05/15/2026 87.34 K $1.09 M   100.00% 0.07%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 79.49 K $993.61 K   100.00% 0.06%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 05/15/2026 74.31 K $928.90 K   100.00% 0.06%
BARCLAYS PLC 05/15/2026 70.89 K $886.18 K   100.00% 0.06%
HRT FINANCIAL LP 05/14/2026 58.76 K $734.00 K   100.00% 0.05%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 50.22 K $627.76 K   100.00% 0.04%
TD ASSET MANAGEMENT INC 05/11/2026 42.87 K $535.83 K   100.00% 0.03%
SUMITOMO MITSUI TRUST HOLDINGS, INC. 04/30/2026 40.34 K $504.30 K   100.00% 0.03%
NIKKO ASSET MANAGEMENT AMERICAS, INC. 05/07/2026 40.34 K $499.46 K   100.00% 0.03%
SQUAREPOINT OPS LLC 05/15/2026 37.20 K $465.04 K   100.00% 0.03%
BANK OF AMERICA CORP /DE/ 05/18/2026 34.20 K $427.45 K   100.00% 0.03%
FEDERATED HERMES, INC. 05/11/2026 30.00 K $375.00 K   100.00% 0.02%
TUDOR INVESTMENT CORP ET AL 05/15/2026 23.83 K $297.91 K   100.00% 0.02%
IQ EQ FUND MANAGEMENT (IRELAND) LTD 05/11/2026 19.20 K $240.04 K   100.00% 0.02%
Y-INTERCEPT (HONG KONG) LTD 04/27/2026 18.36 K $229.53 K   100.00% 0.01%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 17.46 K $218.20 K   100.00% 0.01%
HUDSON BAY CAPITAL MANAGEMENT LP 05/13/2026 16.68 K $208.48 K   100.00% 0.01%
BREVAN HOWARD CAPITAL MANAGEMENT LP 05/15/2026 12.57 K $157.14 K   100.00% 0.01%
DIAMETRIC CAPITAL, LP 05/15/2026 10.50 K $131.21 K   100.00% 0.01%
PARALLEL ADVISORS, LLC 06/03/2026 5.55 K $69.38 K   100.00% 0.00%

Generate Biomedicines Inc institutional Ownership - FAQ's

During the previous two years, 56 institutional investors and hedge funds held shares of Generate Biomedicines Inc. The most heavily invested institutionals were:

Flagship Pioneering Inc.: 62.67 M

FMR LLC: 4.22 M

Capital World Investors: 4 M

BRAIDWELL LP: 3.59 M

JPMORGAN CHASE & CO: 2.95 M

PRICE T ROWE ASSOCIATES INC /MD/: 2.11 M

72.41% of Generate Biomedicines Inc stock is owned by institutional investors.

Institutional investors have bought a total of 92.69 M shares in the last 24 months. This purchase volume represents approximately $1.13 B in transactions.